Physician profile
Gene Liu
NPI 1972517167
$13,823.20
in general payments reported to CMS, 2019-2025
15 companies · $4,989 in 2025
The $4,989 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $735 · 2022: $248 · 2023: $3,871 · 2024: $3,979 · 2025: $4,989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,597 · Food and Beverage: $3,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,597.00 |
| Food and Beverage | $3,242.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $9,765.30 | 2023-2025 | Hopkins, N.A. |
| Aerin Medical INC. | $1,016.93 | 2021-2025 | |
| Stryker Corporation | $635.00 | 2021-2025 | Scopis Ent, Xpress Loprofile |
| Inspire Medical Systems, INC. | $488.44 | 2024-2025 | Inspire |
| Smith+Nephew, INC. | $419.85 | 2021-2025 | Tula, Halo |
| Acclarent, INC | $385.29 | 2021-2024 | Relieva Spinplus, Acclarent Aera, Trudi Nav Cable |
| Preceptis Medical, INC. | $350.85 | 2024-2025 | Hummingbird Tympanostomy Tube System |
| Integra Lifesciences Corporation | $197.29 | 2021-2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Medtronic, INC. | $154.58 | 2025 | |
| Baxter Healthcare | $146.46 | 2024 | |
| Axogen | $95.30 | 2023 | Avance Nerve Graft |
| Takeda Pharmaceuticals U.S.A., INC. | $74.37 | 2021 | |
| Cochlear Americas | $45.62 | 2023 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Glaxosmithkline, LLC. | $28.65 | 2024 | Nucala |
| Hologic Sales and Service, LLC | $19.27 | 2024 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.